Cargando…

Infiltrative Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With a Single High-Dose Y90 Radioembolization and Subsequent Liver Transplantation Without a Recurrence

BACKGROUND: Infiltrative hepatocellular carcinoma with macrovascular invasion is a relatively rare presentation and usually fatal disease. METHODS: Both patients exceeded Milan and University of California-San Francisco (UCSF) criteria, and per Barcelona Clinic Liver Cancer group guidelines, they we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dendy, Meaghan S., Camacho, Juan C., Ludwig, Johannes M., Krasinskas, Alyssa M., Knechtle, Stuart J., Kim, Hyun S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Liver Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585422/ https://www.ncbi.nlm.nih.gov/pubmed/28894793 http://dx.doi.org/10.1097/TXD.0000000000000707

Ejemplares similares

Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience
por: Miura, Kohei, et al.
Publicado: (2018)

DCD Liver Grafts Can Safely Be Used for Recipients With Grade I–II Portal Vein Thrombosis: A Multicenter Analysis
por: Mercado, Lydia A., et al.
Publicado: (2022)

Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention
por: Yip, James, et al.
Publicado: (2016)

Percutaneous Direct Puncture of Retropancreatic Splenic Vein and Portal Thrombectomy in a Patient With Liver Transplantation and Simultaneous Splenectomy
por: Hara, Takanobu, et al.
Publicado: (2022)

Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
por: Xing, Minzhi, et al.
Publicado: (2018)

Significant Hyperfibrinolysis in a Patient With Intracardiac Thrombosis: To Give Antifibrinolytics or Not?
por: Simon, Eric R., et al.
Publicado: (2019)

Retransplantation in Late Hepatic Artery Thrombosis: Graft Access and Transplant Outcome
por: Buchholz, Bettina M., et al.
Publicado: (2017)

Transfusion-free Retransplantation for Post–liver Transplantation Hepatic Artery Thrombosis: How Much Augmentation Is Too Much?
por: Mulgaonkar, Ashwini, et al.
Publicado: (2021)

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis
por: Dendy, Meaghan S., et al.
Publicado: (2017)

Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSA
por: O’Leary, Jacqueline G., et al.
Publicado: (2023)

A Systematic Review on the Safety and Effectiveness of yttrium-90 Radioembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Jia, Zhongzhi, et al.
Publicado: (2016)

Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival
por: Somma, Francesco, et al.
Publicado: (2019)

Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
por: Liu, Jason, et al.
Publicado: (2021)

Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement
por: Şener, Nur, et al.
Publicado: (2023)

Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant
por: Kutaiba, Numan, et al.
Publicado: (2018)

A National Survey of Hepatocellular Carcinoma Surveillance Practices Following Liver Transplantation
por: Aggarwal, Avin, et al.
Publicado: (2020)

Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and Management
por: Shaw, Brian I., et al.
Publicado: (2019)

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
por: Tse, Chung Sang, et al.
Publicado: (2020)

Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma
por: Shaikh, Anjiya, et al.
Publicado: (2022)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
por: Au, Kin-Pan, et al.
Publicado: (2021)

Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma
por: Weinfurtner, Kelley, et al.
Publicado: (2020)

Magnetic Resonance Imaging Predictors of Hepatocellular Carcinoma Progression and Dropout in Patients in Liver Transplantation Waiting List
por: Baghdadi, Azarakhsh, et al.
Publicado: (2022)

T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices
por: Durkin, Claire, et al.
Publicado: (2020)

Understanding the Impact of Pneumonia and Other Complications in Elderly Liver Transplant Recipients: An Analysis of NSQIP Transplant
por: Schnickel, Gabriel T., et al.
Publicado: (2021)

Recurrent Hepatocellular Carcinoma in an Adult With Alagille Syndrome Treated With Liver Resection Followed by Liver Transplantation: A Rare Case Report
por: Galvez, Daniel, et al.
Publicado: (2020)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
por: Pracht, M., et al.
Publicado: (2013)

Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?
por: Barbas, Andrew S., et al.
Publicado: (2018)

Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant Recipients
por: Echeverri, Juan, et al.
Publicado: (2017)

The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New Zealand
por: Howell, Jess, et al.
Publicado: (2022)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
por: Hur, Moon Haeng, et al.
Publicado: (2023)

Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray
por: Okubo, Keita, et al.
Publicado: (2016)

The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors
por: Hidaka, Masaaki, et al.
Publicado: (2016)

Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated With Improved Postreperfusion Hemodynamics
por: Angelico, Roberta, et al.
Publicado: (2016)

Reluctance to Accept Alcohol Treatment by Alcoholic Liver Disease Transplant Patients: A Qualitative Study
por: Heyes, Cathy M., et al.
Publicado: (2016)

Liberation From Renal Replacement Therapy After Cadaveric Liver Transplantation
por: Hilmi, Ibtesam A., et al.
Publicado: (2016)

Ethylene Glycol Poisoning Should Not Contraindicate Liver Donation
por: Burman, Alisha, et al.
Publicado: (2017)

Adapting the Surgical Apgar Score for Perioperative Outcome Prediction in Liver Transplantation: A Retrospective Study
por: Pearson, Amy C. S., et al.
Publicado: (2017)

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_adlniup1f5tu030o6vmbarltne